Thomas Jefferson University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Thomas Jefferson University sits in the top decile of US sponsors by registered trial count (#118 of 15,742 sponsors by registered trial count).
Thomas Jefferson University: 292 sponsored US clinical trials, 54 recruiting.
Thomas Jefferson University sponsors 292 registered US clinical trials on ClinicalTrials.gov, 54 of them currently recruiting, and 182 completed. 46 of these trials are in Phase 3-4 (later-stage) and 73 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Malignant Solid Neoplasm, with 4 trials.
Top-decile sponsor footprint
Thomas Jefferson University ranks in the top decile of sponsors by registered trial count (#118 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
182 of 210 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
292 total, page 6 of 6
Optivol Diagnostic Data for Discharge in Heart Failure
NCT00420108
Research Study of Treatment for Winter Depression With Different Colors of Light
NCT00269633
Measuring G Protein-coupled Receptor Kinase-2 (GRK2) in the Blood to Diagnose and Treat Patients With Heart Failure
NCT00419965
Extracellular Matrix Marker of Arrhythmia Risk (EMMA)
NCT00376532
Safety Study of Elvucitabine in HIV-1 Subjects
NCT00405249
A Research Study to Examine Cutaneous Allodynia and Cluster Headache
NCT00329836
A Research Study Examining Migranal and Skin Sensitivity in Subjects With Migraine
NCT00335777
Prevalence of Phonophobia and Cutaneous Allodynia in Episodic Migraineurs
NCT00386880
Androgen Effect on Klinefelter Syndrome Motor Outcome
NCT00348946
Postoperative Analgesia After Shoulder Replacement
NCT01003860
A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy
NCT00359320
A Research Study To Compare Two Kinds Of Daily Headache
NCT00335803
The Influence of Hypnotic Medications on Sleep Arousal and Its Effect on Gastroesophageal Reflux
NCT00462137
Research Study to Determine Sensitivity to Gentle Touch and Pressure During an Active Migraine Attack.
NCT00329771
Research Study of Greater Occipital Nerve Block As A Treatment For Prolonged Migraine Attacks
NCT00329732
Steroid Free Immunosuppression in Liver Transplantation
NCT00296244
Wellbutrin XL, Major Depressive Disorder and Breast Cancer
NCT00234195
Improving Function in Age-Related Macular Degeneration
NCT00572039
Project COPE:Managing Dementia at Home
NCT00259454
Research Study Examining Nerve Block for Migraine
NCT00203346
A Research Study to Examine the Difference Between Local Anesthetics Alone and Local Anesthetics Plus Steroids in the Treatment of Chronic Headache
NCT00203294
A Research Study to Test (2) Two Different Types of Feeding Tubes Used in the Intensive Care Unit
NCT00245687
Pilot Study of Terazosin in Treatment of Antidepressant Induced Excessive Sweating
NCT00237510
Incidence and Patterns of Nausea/Vomiting With Combined Chemotherapy and Radiation
NCT00716157
A Double-Blind, Placebo-Controlled Study Examining the Use of Topiramate in the Treatment of Cluster Headache
NCT00203190
A Research Study Examining the Use of Olanzapine for the Prevention of Migraine
NCT00203307
Buprenorphine for the Treatment of Neonatal Abstinence Syndrome
NCT00521248
Project TAP: Tailored Activities Project
NCT00259467
A Study Examining the Use of a Migraine Medicine in the Treatment of Two Migraine Attacks in Patients Who Have Increased Skin Sensitivity
NCT00203268
The Effects of Nexium on the Side Effects Associated With a Colonoscopy Prep
NCT00225238
Does Fetal Fibronectin and Ultrasound Cervical Length Help in the Evaluation of Women With Suspected Preterm Labor?
NCT00371046
An Open Label Study Using Consecutive Intravenous Depacon With Oral Depakote ER for the Treatment of Cluster Headaches.
NCT00203242
Research Study to Test Safety and Effectiveness of Investigational Drug in Patients With Trigeminal Neuralgia
NCT00203229
Clinical Study Examining Use of an Over-the-Counter Supplement for the Prevention of Menstrually-Associated Migraine Headache
NCT00203255
A Clinical Study Examining the Safety and Effectiveness of a New Medication (Keppra®) for the Prevention of Migraine Headaches
NCT00203216
Cardiac Rhythm Abnormalities in Patients With Refractory Epilepsy at High Risk for Sudden Death
NCT00203333
Project ACT: Advancing Caregiving Techniques
NCT00259480
Preventing Depression in Patients With Macular Degeneration
NCT00042211
Telesupport: Evaluation of Professionally Led Support Groups for Caregivers
NCT00259415
Project ABLE:Advancing Better Living for Elders
NCT00249925
GM1 Ganglioside Effects on Parkinson's Disease
NCT00037830
The Effect of Androgen and Growth Hormone on Height and Learning in Girls With Turner Syndrome
NCT00029159
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 39 |
| Phase 2 | 34 |
| Phase 3 | 19 |
| Phase 4 | 27 |
What is open in the Thomas Jefferson University pipeline
54 recruiting of 292 indexed (18% open); 182 completed (62%).
Phase mix: 46 late (III/IV) vs 73 early (I/II) (early-phase heavy).
Top condition: Malignant Solid Neoplasm (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Thomas Jefferson University: open-pipeline peers nationwide
Peers matched on 292 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Thomas Jefferson University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 292 trials (± recruiting share)
- University of Michigan Rogel Cancer Center · 292 trials · 15% recruiting
- University of Missouri-Columbia · 291 trials · 19% recruiting
- Kaiser Permanente · 294 trials · 7% recruiting
- Eisai · 287 trials · 2% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Florida Atlantic University · 19% recruiting · 27 trials
- Institut de Recherches Internationales Servier · 19% recruiting · 27 trials
- Natera · 19% recruiting · 27 trials
- Nemours Children's Clinic · 19% recruiting · 108 trials
Related
What to do with this Thomas Jefferson University page
292 registered trials is a research-attention snapshot, not an endorsement of Thomas Jefferson University or any single study.
- 54 of Thomas Jefferson University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Malignant Solid Neoplasm is the condition Thomas Jefferson University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Malignant Solid Neoplasm trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Thomas Jefferson University pipeline card: 292 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.